Senomyx Now Covered by Analysts at Craig Hallum (SNMX)
Research analysts at Craig Hallum started coverage on shares of Senomyx (NASDAQ:SNMX) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
In other Senomyx news, CFO Antony E. Rogers sold 2,997 shares of the company’s stock on the open market in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $8.41, for a total transaction of $25,204.77. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Senomyx (NASDAQ:SNMX) opened at 8.35 on Thursday. Senomyx has a one year low of $1.81 and a one year high of $12.74. The stock’s 50-day moving average is $7.42 and its 200-day moving average is $7.73. The company’s market cap is $355.0 million.
Senomyx (NASDAQ:SNMX) last released its earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.02. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.60 million. During the same quarter in the previous year, the company posted ($0.07) earnings per share. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. Analysts expect that Senomyx will post $-0.24 EPS for the current fiscal year.
A number of other firms have also recently commented on SNMX. Analysts at Lake Street Capital initiated coverage on shares of Senomyx in a research note on Monday, June 9th. They set a “buy” rating and a $14.00 price target on the stock. Separately, analysts at Zacks upgraded shares of Senomyx from an “underperform” rating to a “neutral” rating in a research note on Friday, May 2nd. They now have a $7.70 price target on the stock. Finally, analysts at Needham & Company LLC initiated coverage on shares of Senomyx in a research note on Friday, April 4th. They set a “buy” rating and a $16.00 price target on the stock. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $10.55.
Senomyx, Inc is focused on using taste receptor-based assays and screening technologies to discover and develop flavors, flavor enhancers and bitter blockers for the packaged food, beverage and ingredient supply industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.